vimarsana.com

Page 6 - Positive Predictive Value News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |LungLife AI Announcements | LungLife AI: Confirmation of Issue Price & Admission to AIM

Investegate |LungLife AI Announcements | LungLife AI: Confirmation of Issue Price & Admission to AIM
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions

PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 3, 2021 /PRNewswire/ As the world has adapted to the initial phase of the global pandemic, and vaccines are being manufactured

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging Getty Images January 18, 2021   Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a positron emission tomography (PET) imaging radiopharmaceutical being studied for potential use in detecting recurrent brain metastases. The REVELATE study is a Phase 3, multi-center, single-arm imaging study being conducted in the United States. Its purpose is to assess the diagnostic performance of 18F-fluciclovine PET in detecting recurrent brain metastases in patients previously treated with radiation therapy. The firs

COVID Gone Crazy - An Epidemic Of Positive Tests

COVID Gone Crazy - An Epidemic Of Positive Tests Published: January 11, 2021 In the setting of COVID-19, almost every country in the world closed its borders, locked down its citizens, and forced businesses to close. Today, most governments still restrict travel, economic activity, and social gatherings. The justification for these unprecedented measures has been a growing number of COVID-19 cases. This has unleashed an epidemic of COVID testing - with PCR and rapid antigen tests as the means of identifying positive COVID cases. Our very own  Dr. John Hunt examines the science behind COVID testing, whether the testing paradigms are effective, and the rationality behind government response to the virus.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.